Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands
- PMID: 18640030
- DOI: 10.1016/j.ejca.2008.06.001
Substantial increase in the use of adjuvant systemic treatment for early stage breast cancer reflects changes in guidelines in the period 1990-2006 in the southeastern Netherlands
Abstract
Background: This study evaluated trends in adjuvant systemic treatment among breast cancer patients and analyzed the factors on which treatment choice was based.
Patients and methods: Patients diagnosed with early stage breast cancer in 1990-2006 were selected from the registry of the Comprehensive Cancer Centre South (n=8261). The probability of receiving therapy was determined per characteristic for the periods 1990-1997, 1998-2001 and 2002-2006, separately.
Results: The use of any adjuvant systemic treatment increased from 37% in 1990-1997 to 51% in 1998-2001 and 53% in 2002-2006 (p for trend < 0.0001). In the period 1990-1997, lymph node status (positive vs. negative: probability ratio (PR=25.8; 95% CI, 16.5-40.4) and age ( 60 vs. 35 years: PR=0.01; 95% CI, 0.00-0.02) were the main determinants of the likelihood of receiving chemotherapy. From 1998 onwards, age remained the most important factor in decreasing the likelihood of receiving chemotherapy. During 1990-1997 the use of hormonal therapy was mainly determined by positive lymph node status (PR=35; 95% CI, 25-49) and age ( 70 vs. 35 years: PR=9.3; 95% CI, 4.4-20), whereas positive hormone receptor status mainly affected hormonal therapy use (PR=17; 95% CI, 10-28) in the period 2002-2006. Marked differences were observed between hospitals in the adoption of adjuvant systemic treatment for node-negative patients.
Conclusions: The impact of patient and tumour characteristics on treatment choice varied over time, reflecting major changes in the Dutch treatment guidelines. Patients older than 70 years received almost no chemotherapy.
Similar articles
-
Improved survival for women with stage I breast cancer in south-east Sweden: a comparison between two time periods before and after increased use of adjuvant systemic therapy.Acta Oncol. 2009;48(4):504-13. doi: 10.1080/02841860902718754. Acta Oncol. 2009. PMID: 19235568
-
[Determining factors for adjuvant treatment of breast cancer in the Côte d'Or region 1982-1990. Registry of gynecologic cancers at the Côte d'Or].Bull Cancer. 1996 Jan;83(1):54-62. Bull Cancer. 1996. PMID: 8672857 French.
-
Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients.Acta Oncol. 2009;48(4):514-21. doi: 10.1080/02841860802620613. Acta Oncol. 2009. PMID: 19107621
-
Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals.Crit Rev Oncol Hematol. 2011 Aug;79(2):196-204. doi: 10.1016/j.critrevonc.2010.06.005. Epub 2010 Jul 23. Crit Rev Oncol Hematol. 2011. PMID: 20655243 Review.
-
[Early-stage breast cancer - strategies for adjuvant systemic therapy].Handchir Mikrochir Plast Chir. 2008 Aug;40(4):230-8. doi: 10.1055/s-2008-1038926. Epub 2008 Aug 20. Handchir Mikrochir Plast Chir. 2008. PMID: 18716990 Review. German.
Cited by
-
Regional variation in breast cancer treatment in the Netherlands and the role of external peer review: a cohort study comprising 63,516 women.BMC Cancer. 2014 Aug 16;14:596. doi: 10.1186/1471-2407-14-596. BMC Cancer. 2014. PMID: 25129126 Free PMC article.
-
Comprehensive trends in incidence, treatment, survival and mortality of first primary invasive breast cancer stratified by age, stage and receptor subtype in the Netherlands between 1989 and 2017.Int J Cancer. 2021 May 1;148(9):2289-2303. doi: 10.1002/ijc.33417. Epub 2020 Dec 16. Int J Cancer. 2021. PMID: 33252836 Free PMC article.
-
Predictors of enduring clinical distress in women with breast cancer.Breast Cancer Res Treat. 2016 Aug;158(3):563-72. doi: 10.1007/s10549-016-3896-7. Epub 2016 Jul 14. Breast Cancer Res Treat. 2016. PMID: 27417105 Free PMC article.
-
Return to work after cancer diagnosed in 2002, 2005 and 2008.J Occup Rehabil. 2011 Sep;21(3):335-41. doi: 10.1007/s10926-011-9319-z. J Occup Rehabil. 2011. PMID: 21796373 Free PMC article.
-
A longitudinal mixed methods study on changes in body weight, body composition, and lifestyle in breast cancer patients during chemotherapy and in a comparison group of women without cancer: study protocol.BMC Cancer. 2019 Jan 5;19(1):7. doi: 10.1186/s12885-018-5207-7. BMC Cancer. 2019. PMID: 30611243 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials